1. Home
  2. ATAI vs HYI Comparison

ATAI vs HYI Comparison

Compare ATAI & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • HYI
  • Stock Information
  • Founded
  • ATAI 2018
  • HYI 2010
  • Country
  • ATAI Germany
  • HYI United States
  • Employees
  • ATAI N/A
  • HYI N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • HYI Investment Managers
  • Sector
  • ATAI Health Care
  • HYI Finance
  • Exchange
  • ATAI Nasdaq
  • HYI Nasdaq
  • Market Cap
  • ATAI 282.6M
  • HYI 262.0M
  • IPO Year
  • ATAI 2021
  • HYI N/A
  • Fundamental
  • Price
  • ATAI $1.41
  • HYI $11.64
  • Analyst Decision
  • ATAI Strong Buy
  • HYI
  • Analyst Count
  • ATAI 3
  • HYI 0
  • Target Price
  • ATAI $10.50
  • HYI N/A
  • AVG Volume (30 Days)
  • ATAI 1.4M
  • HYI 50.6K
  • Earning Date
  • ATAI 05-19-2025
  • HYI 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • HYI 9.59%
  • EPS Growth
  • ATAI N/A
  • HYI N/A
  • EPS
  • ATAI N/A
  • HYI N/A
  • Revenue
  • ATAI $308,000.00
  • HYI N/A
  • Revenue This Year
  • ATAI $65.58
  • HYI N/A
  • Revenue Next Year
  • ATAI N/A
  • HYI N/A
  • P/E Ratio
  • ATAI N/A
  • HYI N/A
  • Revenue Growth
  • ATAI N/A
  • HYI N/A
  • 52 Week Low
  • ATAI $1.03
  • HYI $10.99
  • 52 Week High
  • ATAI $2.57
  • HYI $12.24
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 44.57
  • HYI 49.96
  • Support Level
  • ATAI $1.36
  • HYI $11.55
  • Resistance Level
  • ATAI $1.54
  • HYI $11.69
  • Average True Range (ATR)
  • ATAI 0.09
  • HYI 0.13
  • MACD
  • ATAI -0.00
  • HYI 0.02
  • Stochastic Oscillator
  • ATAI 0.00
  • HYI 65.71

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: